en
E-mail us

Avoiding the Next Ritonavir

Crystal Pharmatech is happy to announce our new webinar “Avoiding the Next Ritonavir” is open for registration.


Please join us by the following regisrtaion link:

https://attendee.gotowebinar.com/register/8088694053203239951


Title:  Avoiding the Next Ritonavir

Time: Thursday, July 21, 2022 | 1 PM EDT


Abstract:

Knowledgeable development scientists have the fear of a late-stage crystal form popping out and dropping bioavailability to the point where supplies are pulled from the shelves. Advancements over the last 30 years have positioned us to act instead of reacting characterization tools that combine to identify specific compound risks that can be acted on. We outline what can be done in-silico with just a 2D structure and zero benchwork. Then we secribe the power of coupling these advacnements with minimal but advanced characterization data. Let us how you a real-world example of how this technology moves your moecule to medicine and minimizes the risk of another Ritonavir.


Speakers:

cdmo-in-pharma.jpg


Related CRO & CDMO Services

Related Updates in Crystal Pharmatech

Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303